Searchable abstracts of presentations at key conferences in endocrinology

ea0099rc5.3 | Rapid Communications 5: Pituitary and Neuroendocrinology | Part I | ECE2024

Hypogonadotropic hypogonadism in patients with non-functioning pituitary adenomas before and after transsphenoidal surgery – A prospective study

Hantelius Victor , Johannsson Gudmundur , Hallen Tobias , Skoglund Thomas , Ragnarsson Oskar

Background: Hypopituitarism is common in patients with pituitary tumors. Still, the influence of pituitary tumor surgery on gonadal function and reproductive health remains underexplored.Objective: a) To assess gonadal function and its impact on quality of life (QoL) in patients with non-functioning pituitary adenomas (NFPA) before and after transsphenoidal surgery (TSS), b) to identify factors that predict recovery of gonadal function following TSS, and...

ea0041oc13.3 | Pituitary Clinical | ECE2016

Increased glucocorticoid replacement doses are associated with excess mortality in patients with non-functioning pituitary adenoma

Hammarstrand Casper , Hallen Tobias , Andersson Eva , Skoglund Thomas , Nilsson Anna G , Ragnarsson Oskar , Johannsson Gudmundur , Olsson Daniel S

Background: Patients with secondary adrenal insufficiency have an excess mortality. Data concerning the influence of the glucocorticoid replacement regime on mortality is sparse.Objective: To investigate if the total daily dose of glucocorticoid replacement has an effect on mortality in patients with non-functioning pituitary adenoma (NFPA).Method: Patients with NFPA treated for hypopituitarism in the western region of Sweden were ...

ea0070aep605 | Pituitary and Neuroendocrinology | ECE2020

An education programme for patients with pituitary tumours and their relatives; preliminary results

Tiberg Persson Jenny , Jakobsson Sofie , Cid Käll Kristina , Kullin Lena , Olofsson Ann-Charlotte , Wittboldt Ia , Skoglund Thomas , Trimpou Penelope , Jakobsson Ung Eva , Johannsson Gudmundur

Background: Patients with pituitary tumour live with life-long consequences of their disease. The first year after pituitary surgery represents a time period of symptoms, fear of tumour recurrence, existential concerns as well as extensive medical evaluations and decisions about hormone replacement. To increase wellbeing, a person-centred care practice up to 1 year after pituitary surgery covering self-management support, accessibility and continuity has been implemented and a...